Top Pharmaceutical Stocks To Research – May 24th

D-Wave Quantum, Eli Lilly and Company, Johnson & Johnson, Thermo Fisher Scientific, and Merck & Co., Inc. are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares of companies engaged in the research, development, manufacturing, and marketing of drugs and medical therapies. Investors buy pharmaceutical stocks to gain exposure to potential breakthroughs in drug discovery and to benefit from commercialized therapies, though these equities can be volatile due to clinical trial outcomes and regulatory approvals. Their performance is often influenced by patent lifecycles, healthcare policy changes, and global demand for treatments. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of NYSE:QBTS traded down $0.29 on Friday, hitting $18.76. The company’s stock had a trading volume of 148,422,253 shares, compared to its average volume of 42,295,348. D-Wave Quantum has a 12 month low of $0.75 and a 12 month high of $19.77. The company has a market capitalization of $5.46 billion, a price-to-earnings ratio of -44.65 and a beta of 0.90. The stock’s 50-day moving average is $8.76 and its two-hundred day moving average is $6.66.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE:LLY traded down $1.21 on Friday, hitting $713.99. The company’s stock had a trading volume of 2,631,160 shares, compared to its average volume of 3,615,016. Eli Lilly and Company has a 12 month low of $677.09 and a 12 month high of $972.53. The company has a market capitalization of $676.67 billion, a price-to-earnings ratio of 60.97, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48. The stock’s 50-day moving average is $789.29 and its two-hundred day moving average is $803.00. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE:JNJ traded up $0.51 on Friday, hitting $153.12. The company’s stock had a trading volume of 6,727,130 shares, compared to its average volume of 7,971,368. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $169.99. The company has a market capitalization of $368.41 billion, a price-to-earnings ratio of 23.02, a price-to-earnings-growth ratio of 2.56 and a beta of 0.42. The stock’s 50-day moving average is $155.24 and its two-hundred day moving average is $153.72. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of NYSE:TMO traded down $6.95 on Friday, hitting $393.53. The company’s stock had a trading volume of 2,318,052 shares, compared to its average volume of 1,865,466. Thermo Fisher Scientific has a 12 month low of $390.50 and a 12 month high of $627.88. The company has a market capitalization of $148.56 billion, a price-to-earnings ratio of 23.81, a price-to-earnings-growth ratio of 2.99 and a beta of 0.82. The stock’s 50-day moving average is $442.54 and its two-hundred day moving average is $505.23. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.29 and a current ratio of 1.66.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

MRK stock traded down $0.25 during trading hours on Friday, hitting $77.59. 10,899,340 shares of the stock traded hands, compared to its average volume of 12,545,046. The stock has a 50-day simple moving average of $81.76 and a 200 day simple moving average of $91.46. Merck & Co., Inc. has a one year low of $73.31 and a one year high of $134.63. The company has a market cap of $194.83 billion, a P/E ratio of 11.53, a P/E/G ratio of 0.77 and a beta of 0.43. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of 0.79.